Medxtractor Doubles Down on B2B Licensing & mHealth
Cannabis Law Report
AUGUST 3, 2021
Unlike most other ailments, there isn’t a simple test that physicians can use to diagnose a patient with a disorder. CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. (CSE: Source: Data Bridge.
Let's personalize your content